Prof. Kusakabe is straightforward and articulate in his manner of speech. Kyushu University’s silkworm research has been gaining media attention for KAICO, its big bug startup.
In the lab stands a bronze of Prof. Yoshimaro Tanaka, the founder of the Laboratory of Silkworm Sciences at Kyushu University. He stands quietly, keeping a watchful eye over his successors’ research.
Prof. Kusakabe spends his days with fellow researchers comparing, verifying, and testing protein data extracted from silkworms. It’s hard work, but it’s satisfying when test results turn out as expected. But he says that even when they don’t, it’s always exciting to try and figure out why!
Prof. Kusakabe is straightforward and articulate in his manner of speech. Kyushu University’s silkworm research has been gaining media attention for KAICO, its big bug startup.
In the lab stands a bronze of Prof. Yoshimaro Tanaka, the founder of the Laboratory of Silkworm Sciences at Kyushu University. He stands quietly, keeping a watchful eye over his successors’ research.
Prof. Kusakabe spends his days with fellow researchers comparing, verifying, and testing protein data extracted from silkworms. It’s hard work, but it’s satisfying when test results turn out as expected. But he says that even when they don’t, it’s always exciting to try and figure out why!
Simply put, we are studying the efficient production of proteins using silkworm bioresources. We extract the genes of useful proteins from various organisms and insert them into a vector, a virus that can act as a gene carrier. We then take this genetically modified virus and infect silkworms to produce recombinant proteins.
In 2017, we ended a seven-year search when we found a silkworm capable of producing large amounts of proteins that we can use to make vaccines and other pharmaceutical materials. Live vaccines for infectious diseases are usually made by replicating attenuated viruses, which are injected into fertilized chicken eggs and other animal cells. However, the downside to using these vaccines is that most of them are patented outside of Japan, adding time to the vaccine development process. And considering possible side effects, we can't say that live vaccines are entirely risk-free. With vector-based, genetically modified vaccines, on the other hand, we can quickly produce safe vaccines domestically at lower costs, which is certainly an advantage. Even so, the domestic market for vaccine development remains quite small, due in part to already existing vaccines and the absence of infrastructure for genetically modified vaccine development.
But what would we do if an unknown virus were to spread across Japan? With current live vaccines taking ten months or more to produce, we wouldn't be able to respond in time if a pandemic hit. With massive silkworm factories, however, we would gain the ability to mass-produce genetically engineered vaccines on the fly. We are still in the early research stages for human vaccine production, but I would like to stress that silkworm factories are one of our best options for creating a system capable of protecting the entire country from an infectious disease outbreak.
As of April 2018, we have already begun to make this vision a reality by creating KAICO, a company founded to commercialize joint research by the School of Agriculture and the School of Engineering. Our core business will focus on three areas: reagents, diagnostic agents, and vaccines. From a developmental standpoint, the possibilities are endless in terms of meeting the needs of modern medicine, but it will still take time to create viable solutions. Nevertheless, I’m confident that our research today will one day inform the production of vaccines needed to protect the nation from new infectious diseases.


Since its founding, Kyushu University has been a leader in silkworm genomics and for decades has managed its own original strain of silkworm and maintained close to 500 other lines of silkworm bioresources through inbreeding. And with cryopreservation technology allowing for on-demand revival of other silkworm strains, it is plain to see that Kyushu University is one of the best environments for silkworm research in Asia.
University research is a slow and steady process, but it's a thrill to experience firsthand the direct connection to the future that only research can provide. At the Research Center for New Industry Creation in the Entomological Sciences at the Faculty of Agriculture, where I serve as director, we are dedicated to developing new insect industries. We work together with the best insect science researchers in the world to integrate resources, share big data, and create a global platform for insect science research.Our research is very rewarding because we get to collaborate outside the university to create processes that will lead to ever greater possibilities.
A lot of my work involves silkworms, but first and foremost, I'm a researcher. And the best thing about being a researcher is being the first person to understand something that the rest of the world has yet to discover. Discovery begins with curiosity, and it can have a real impact on the world. Once you've experienced the joy of making something from nothing, you just can’t stop.